Hospital-acquired infections-appropriate statistical treatment is urgently needed!

International Journal of Epidemiology

Volumn 42, Issue 5, 2013, Pages 1502-1508

  Schumacher, Martin ^a   Allignol, Arthur ^a   Beyersmann, Jan ^a,b   Binder, Nadine ^a   Wolkewitz, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Cohort studies; Competing risks; Hospital acquired infections; Length bias; Time dependent bias

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTICS; COHORT ANALYSIS; HOSPITAL SECTOR; INFECTIOUS DISEASE; RISK FACTOR;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL RESEARCH; CONFIDENCE INTERVAL; HAZARD RATIO; HEALTH STATISTICS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MATHEMATICAL MODEL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STANDARD; STATISTICAL ANALYSIS; COHORT ANALYSIS; CROSS INFECTION; INTENSIVE CARE UNIT; PNEUMONIA, BACTERIAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; STATISTICS; TIME FACTOR;

COHORT STUDIES; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MODELS, STATISTICAL; PNEUMONIA, BACTERIAL; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84886378915     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyt111     Document Type: Article

References (50)

1. Saleh SS, Callan M, Therriault M, Landor N. The cost impact of hospital-acquired conditions among critical care patients. Med Care 2010;48:518-26.
2. Crnich CJ. Estimating excess length of stay due to central line-associated bloodstream infection: separating the wheat from the chaff. Infect Control Hosp Epidemiol 2010; 31:1115-17.
3. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011;14:381-86.
4. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-70.
5. Andersen PK, Abildstrom SZ, Rosthøj S. Competing risks as a multi-state model. Stat Meth Med Res 2002;11: 203-15.
6. Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res 2002;11: 91-115.
7. Beyersmann J, Gastmeier P, Grundmann H et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006;27:493-99.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
9. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-20.
10. Van Walraven C, Davis D, Forster AJ, Wells GA. Timedependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004; 57:672-82.
11. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008;61:1216-21.
12. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998;157:1151-58.
13. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun- Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:1249-56.
14. Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163:1584-90.
15. Blot S, De Bacquer D, Hoste E et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 2005;26:352-56.
16. Schulgen G, Kropec A, Kappstein I, Daschner F, Schumacher M. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000;53:409-17.
17. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling. Methods Inf Med 2009;48:438-43.
18. De Angelis G, Allignol A, Murthy A et al. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients. J Hosp Infect 2011;78: 86-91.
19. Wolkewitz M, Allignol A, Harbarth S, de Angelis G, Schumacher M, Beyersmann J. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol 2012;65:1171-80.
20. Koller MT, Raatz H, Steyerberg EW, Wolbers M. Competing risks and the clinical community: irrelevance or ignorance? Stat Med 2012;31:1089-97.
21. Aiken AM, Mturi N, Njuguna P et al. Risk and causes of paediatric hospital-acquired bacteraemia in KilifiDistrict Hospital, Kenya: a prospective cohort study. Lancet 2011; 378:2021-27.
22. Grambauer N, Schumacher M, Dettenkofer M, Beyersmann J. Incidence densities in a competing events analysis. Am J Epidemiol 2010;172:1077-84.
23. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J. Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. Methods Inf Med 2007;46:595-600.
24. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 2009;35:826-32.
25. Nguile-Makao M, Zahar JR, Français A et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010;36:781-89.
26. Wolkewitz M, Frank U, Philips G, Schumacher M, Davey P, BURDEN Study Group. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 2011;66:381-86.
27. Aalen OO. Armitage Lecture 2010. Understanding treatment effects: the value of integrating longitudinal data and survival analysis. Stat Med 2012;31:1903-17.
28. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control-studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001;32:1055-61.
29. Doll R. Sir Austin Bradford Hill and the progress of medical science. BMJ 1992;305:1521-26.
30. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council Investigation. Br Med J 1948;1:769-82.
31. Daniels M, Hill AB. Chemotherapy of pulmonary tuberculosis in young adults. An analysis of the combined results of three Medical Research Council Trials. Br Med J 1952;1:1162-68.
32. Doll R, Hill AB. Smoking and carcinoma of the lung; Preliminary report. Br Med J 1950;2:739-48.
33. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J 1956;2:1071-81.
34. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
35. Hill AB. Principles of Medical Statistics. XII - Common fallacies and difficulties. Lancet 1937;1:706-08.
36. Hanley JA, Carrieri MP, Serraino D. Statistical fallibility and the longevity of popes: William Farr meets Wilhelm Lexis. Int J Epidemiol 2006;35:802-05.
37. Webster NR. Professors live longer than doctors: immortality bias in survival analysis. Br J Anaesth 2011;106: 161-63.
38. Farr W. Vital Statistics: A memorial volume of selections from the reports and writings of William Farr with an introduction by Mervyn Susser and Abraham Adelstein. Metuchen, NJ: Scarecrow PR, 1975.
39. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167:492-99.
40. Shintani AK, Girard TD, Eden SK, Arbogast PG, Moons KG, Ely EW. Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med 2009;37: 2939-45.
41. Lévesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010;340: b5087.
42. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. J Clin Oncol 2008;26:3913-15.
43. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation 2008;117:1918-26.
44. Dignam JJ, Zhang Q, Kocherginsky M. The use and interpretation of competing risks regression models. Clin Cancer Res 2012;18:2301-08.
45. Beyersmann J, Schumacher M, Allignol A. Competing risks and multistate models with R. New York: Springer, 2012.
46. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007;26: 2389-430.
47. Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M. Application of multistate models in hospital epidemiology: advances and challenges. Biomed J 2011;53:332-50.
48. Samore M, Harbarth S. A methodologically focused review of the literature in hospital epidemiology and infection control. In Mayhall CG (ed). Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott Williams & Wilkins, 2004.
49. Barnett AG, Batra R, Graves N, Edgeworth J, Robotham J, Cooper B. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009;170:1186-94.
50. Hill AB. Principles of Medical Statistics. London: Lancet, 1937.